Login

Kyndryl CEO Martin Schroeter shared his insights on a significant day shortly after the Opening Bell. 00:10:00

Share On Facebook Share On Twitter

Martin J Schroeter is Chairman/CEO at Kyndryl Holdings Inc. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Farid Basir, Chief Human Capital Officer at Telekom Malaysia, to speak at Asia's largest HR and Work Tech Conference in February.
00:10:00
Dropbox CEO Drew Houston explains how subscribers are leveraging AI-powered tools to address new challenges.|Andrew W. Houston is an American Internet entrepreneur, and the co-founder and CEO of Dropbox
00:10:00
Macron's Victory: Impact on French Business and Talent Retention | Christophe Bavière, CEO, Idinvest Partners.
00:10:00
Zhihao Zheng, CEO of Maoyan Entertainment, discusses the company's listing price and his ambitions for the future of digital entertainment in China.
00:10:00
Watch Vijay Chandok, MD & CEO of ICICI Securities, share insights on key financial topics.
00:10:00
Jeff Holmgren Discusses Trees Corp.'s NEO Debut and Growth Plans | Jeff Holmgren , CFO, Trees Corporation.
00:10:00
The Story Behind Lenity Financial, Inc.: A Journey of Transformation with Mark Bova | Mark Bova, Co-Founders , Lenity Financial, Inc.
00:10:00
Greetings from Mud School | Ed Anderson, General Manager, Baroid Industrial Drilling Products (TS)
00:10:00
"Alumnus Mark Hunting on BP Role and Ropes & Gray Experiences" | Mark Hunting - Senior Counsel of Ropes & Gray, London office, 2014-2016
00:10:00
Ural Manganese: Repurposing Tailings for High Purity Manganese Products in Europe
00:10:00
Antony Beckmand Highlights Major Boost from Middagshvile Drilling and Sulphide Discoveries | Antony Beckmand , CEO, Kuniko Limited.
00:10:00
Neurosciences Avidity - Myotonic Dystrophy | SARAH BOYCE, PRESIDENT & CHIEF EXECUTIVE, FICER OF AVIDITY BIOSCIENCES INC

© 2017 - Neuhu+